athyrium capital management  athyrium opportunities fund aof investor login aof i portal aof ii portal athyrium opportunities fund aof aof ii aof i previous investments athyrium opportunities fund company marketer  counterparty product initial investment date medpro safety products greiner bioone vacuette safety system february  biofire diagnostics biofire filmarray september  verenium verenium various december  ironwood pharmaceuticals ironwood and forest laboratories linzess january  syncardia systems inc syncardia total artificial heart march  progenity inc progenity inc various genetic tests june  tria beauty inc tria beauty skincare products july  innopharma inc various marketing partners specialty injectable and ophthalmic generic pharmaceuticals october  horizon pharma inc horizon pharma various nsaids and actimmune november  universal biosensors inc lifescan jj and siemens point of care poc diagnostics december  pernix therapeutics holdings inc pernix treximet and others february  ikaria inc ikaria inomax february  vivus inc vivus inc qsymia and stendraspedra february  synarcbiocore holdings llc synarcbiocore holdings specialty clinical research services march  retrophin inc alamo pharma services inc chenodal  thiola july  tecomet inc tecomet orthopedic and other contract manufacturing services december  zealand pharma as sanofi lyxumia december  lannett company inc lannett company inc generic pharmaceuticals december   this table lists all investments made by the athyrium opportunities fund home  medpro safety products  mpsp medpro about us board of directorsnews and announcementscontact us investor relations safety products drug deliveryphlebotomyambienativanklonopinmeridiasomatramadolvaliumxanax  rose news  annoucements all news  annoucements previous next medpro agrees to sell patents on three blood collection and infusion products to greiner bioone agreement will also eliminate  million of medpro longterm debt » read more medpro makes charitable donation to sandy hook in lieu of sending holiday cards happy holidays from medpro » read more find medpro at cphi in madrid meet us at innopack  icse booth j this event is located at the feria madr » read more medpro safety products and weimer pharma announce marketing partnership lexington ky  rastatt germany – august   – medpro safety products inc » read more medpro signs letter of intent with specialty pharmaceutical company lexington ky – july   – medpro safety products inc otcbbmpsp a lea » read more crystal research provides update on medpro safety products recent update on medpro safety products published by crystal research reports » read more medpro safety products to participate in two key industry conferences company to highlight its innovative drug delivery solutions at  aaps nationa » read more medpro featured in drug development  delivery may issue prefilled syringes  a container of choice for pharma features medpros prefil » read more whitepaper featured on occupational health  safety website a call to safety why current safety devices are not solving the needlestick is » read more medpro safety products releases  financial results reports on progress and recent corporate developments » read more survey reveals market demand for new prefilled drug delivery platform medpro seeks partnerships to commercialize new cartridge platform safety syring » read more ondrugdelivery publication features medpro article download medpros feature article in ondrugdelivery » read more  medpro inc all rights reserved terms of use  privacy policy contact  site map syndromic infectious disease diagnostics  biofire diagnostics menu home products solutions for healthcare providers for labs for customers filmarray filmarray® link software panels testimonials request a demo research for payors company mission  values careers contact media conferences  events press releases press kit support video library faq continuing education return forms documents sign up for updates  this iframe contains the logic required to handle ajax powered gravity forms syndromic testing the right test the first time rapidly identify infections with symptomdriven testing for healthcare providersfor labsfor customers filmarray® the fastest way to better results the filmarray system from biofire is the new standard for syndromic infectious disease diagnostics simple fast and comprehensive the filmarray delivers accurate results in about an hour the right test the first time can impact all areas of patient care healthcare providers can see faster diagnoses and improved antibiotic stewardship labs can see improved efficiency and reduced costs and downstream testing read more filmarray ® panels the five fdacleared filmarray panels test for viruses bacteria parasites yeast and antimicrobial resistance genes whether you’re trying to select appropriate therapy for a septic patient or determine exactly which respiratory pathogen is making a young child sick the filmarray® system can return answers fast learn more respiratory blood culture id gastrointestinal meningitis biofire diagnostics leading the way with more than  years of molecular experience biofire diagnostics llc sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing as biomérieux’s global center of excellence for molecular diagnostics no other company has fdacleared and ceivd marked assays for more pathogens biofire diagnostics has produced the easiest fastest and most comprehensive multiplex pcr system available the filmarray learn more unique values for clinics labs and customers the combination of fast easy and comprehensive is really powerful these characteristics define the filmarray® system for clinics labs and current customers biofire’s molecular diagnostic solutions provide unique value   for healthcare providers the biofire filmarray® helps healthcare providers improve patient care and satisfaction by providing faster and better results learn more for labs the biofire filmarray easily integrates into clinical laboratories allowing for relevant molecular testing around the clock learn more for customers easy access to information and resources to help current customers use biofire products with confidence learn more request a filmarray demo are you ready to order the filmarray or want to request a free demo please fill out this form to take the next step towards faster results our team is ready to answer all of your questions request a demo enzymes cookies help us deliver our services by using our services you agree to our use of cookies learn more ok close choose a basf website asia pacific americas europe middle east  africa basf global asia pacific americas europe middle east  africa close select your language basf global  this page is available in the following languages english close logged in error logging out hello you are logged in with access to additional information basf ecommerce platform logout login invalid login credentials please login with your username and password username password keep me logged in forgot your password you want to purchase products or view order status from basf se basf ecommerce platform would you like to register to get personalized information register here to get additional information like specific downloads register to basfcom registration is successful lorem ipsum doloramet conseteture sadipscing registration is unsuccessful lorem ipsum doloramet consetetur back to registration form firstname lastname company country please choose your country please choose your country industry please choose your industry sub industry please choose subindustry please choose subindustry street number postal code city phone email desired password repeat password basf user agreement details basf user agreement basf user agreement register you want to purchase products or view order status from basf se basf ecommerce platform forgot your password please provide your registered email id to reset your password reset password link has been sent to provided registration email id please provide a valid registered email id email submit enzymes enzymes contact   basf  we create chemistry  home products  industries  enzymes industrial enzyme solutions basf is a recognized pioneer in the development and commercialization of highperformance enzymes for use in industrial processes basf sells enzymes developed using its unique rd capabilities to satisfy the needs of the global market leveraging its unique patented technology the company harnesses the power of nature and creates products that maximize efficiency while improving environmental performance global challengesthe global population is estimated to reach  billion by  major challenges to support that growth include having enough water food and energy for all while meeting expectations of rising living standards at basf we believe through creating chemistry and leveraging industrial biotechnology we will be able to meet these challenges markets we serve why enzymesfrom enzymes in detergents to enzymes which enhance the nutrition of the food we eat enzymes are part of our everyday lives they make the products we use daily more efficient are naturally biodegradable and have a great safety profile enzymes are part of a growing movement towards the biobased economy why enzymes innovate with uswe invite potential collaborators and customers to engage with basf to jointly collaborate and solve problems together work with us our scienceour technology platform harnesses all of nature’s biodiversity and brings that biodiversity to the commercial realm via enzyme products what we do share linkedin facebook twitter google email print ironwood pharmaceuticals skip to main content you are now leaving ironwoodpharmacom you are now leaving ironwoodpharmacom this link will take you to a website to which our privacy policy does not apply you are solely responsible for your interactions with that website the art and science of making medicineswe’re focused on three goals transforming knowledge into medicines that make a difference for patients creating value that will inspire the continued support of our fellow shareholders and building a team that passionately pursues excellence recent news ironwood pharmaceuticals to host second quarter  investor update call »ironwood pharmaceuticals reports positive topline results from iw phase iib trial in uncontrolled gastroesophageal reflux disease » in our analytical chemistry lab inside ironwood building a topperforming commercial biotech company we are focusing on several important franchises including ibsccic refractory gerd uncontrolled gout and vascular and fibrotic diseases find out more » click here for full us prescribing information including boxed warning »learn more about linzess® »click here for full us prescribing information including limitations of use and boxed warning »learn more about zurampic® » members of our analytical pharmacology team ironwood pharmaceuticals  binney street cambridge ma  tel  fax  about us overview core values management team founders board of directors pharmaceutical advisory committee contact us transparency our medicines overview discovery of linaclotide global strategy rd overview key programs approach collaborate overview accessing additional products globalization investors overview business principles events corp governance financial information stock information investor faqs press releases investor contacts news overview press releases social media multimedia resources join us overview career openings sales openings our community our expertise copyright   ironwood pharmaceuticals inc all rights reserved        privacy policy        terms of service       site design linzess® is a registered trademark of ironwood pharmaceuticals inc zurampic® duzallo™ are registered trademarks of astrazeneca ab corporation or its affiliates and are used herein under license athyrium capital management  athyrium opportunities fund aof investor login aof i portal aof ii portal athyrium opportunities fund aof aof ii aof i previous investments athyrium opportunities fund company marketer  counterparty product initial investment date medpro safety products greiner bioone vacuette safety system february  biofire diagnostics biofire filmarray september  verenium verenium various december  ironwood pharmaceuticals ironwood and forest laboratories linzess january  syncardia systems inc syncardia total artificial heart march  progenity inc progenity inc various genetic tests june  tria beauty inc tria beauty skincare products july  innopharma inc various marketing partners specialty injectable and ophthalmic generic pharmaceuticals october  horizon pharma inc horizon pharma various nsaids and actimmune november  universal biosensors inc lifescan jj and siemens point of care poc diagnostics december  pernix therapeutics holdings inc pernix treximet and others february  ikaria inc ikaria inomax february  vivus inc vivus inc qsymia and stendraspedra february  synarcbiocore holdings llc synarcbiocore holdings specialty clinical research services march  retrophin inc alamo pharma services inc chenodal  thiola july  tecomet inc tecomet orthopedic and other contract manufacturing services december  zealand pharma as sanofi lyxumia december  lannett company inc lannett company inc generic pharmaceuticals december   this table lists all investments made by the athyrium opportunities fund athyrium capital management  athyrium funds investor login aof i portal aof ii portal athyrium  our funds overview our funds our history aof ii in may  athyrium announced a final closing for the athyrium opportunities fund ii aof ii or the fund the fund has  of committed capital the fund is focused on making structured investments in the broader healthcare and life sciences sectors including pharmaceuticals biologics biotechnology specialty and generic pharmaceuticals medical devices and products laboratory and diagnostics products and services healthcare services and healthcare information technology the fund is focused on generating current income and capital gains and has significant flexibility in structuring its investments–possible transaction structures include loans or other highyielding credit investments with or without warrant coverage royalties or royaltybacked investments structured securities preferred stock or convertible securities the fund seeks to make attractive riskadjusted returns and looks to partner with management teams and to provide long term capital to assist in building their businesses the fund can also engage in secondary market transactions aof ii is a successor fund to the athyrium opportunities fund aof i which had a final closing in march  with  million of committed capital separate accounts since its founding athyrium has formed a number of separate account relationships in order to focus on specific opportunities within the life sciences sector nb athyrium llc served as a predecessor to the athyrium opportunities fund   athyrium opportunities fund iii lp  who is raising money  sec filings of fundraisings and investments in hedge funds startups and private equity companies who is raising money athyrium opportunities fund iii lp funding details athyrium opportunities fund iii lp industry pooled investment fundcik number address co athyrium capital management lp  fifth avenue floor  new york phone number  latest news athyrium opportunities fund iii lp raised  from  investors on  athyrium opportunities fund iii lp filings datefiling typeofferedsoldremainingmin investmentinvest countexemption  exlusions new form dindefiniteindefiniteb c csec filing athyrium opportunities fund iii lp raised  in total directors and executives of athyrium opportunities fund iii lp key people in athyrium opportunities fund iii lp andrew hymanpaul wakefieldcourtney paulelin strongjeffrey ferrelljeremy lack similar companiesathyrium partners lp athyrium opportunities fund b lp athyrium opportunities fund ii nonus lp athyrium opportunities fund ii lp athyrium opportunities fund iib master lp athyrium opportunities fund iii nonus a lp athyrium opportunities fund iii nonus b lp athyrium healthcare strategic income  growth idf llc last visited companies lcg hedged equity fund ltd liberty star uranium  metals corp lrt global opportunities lp lindamar partners ii lp livingston hemodialysis partners llc  whoisraisingmoneycom daily updated news about investment into startups hedge funds and private equity companies athyrium opportunities fund ii lp private company information  bloomberg july    am et capital markets company overview of athyrium opportunities fund ii lp snapshot people company overview athyrium opportunities ii is a cosponsored fund of athyrium capital management lp and nb alternatives specializing in structured capital investments with a focus on loans notes convertible securities preferred stock and other equity royalties royaltybacked debt or other structured instruments in mature stage firms the fund seeks to invest across all healthcare verticals including biopharma medical devices diagnostics healthcare services and healthcare information technology financings by the fund can be made in both public and private companies it prefers to invest globally with a focus on north america europe asia and australia it considers investments between  million athyrium opportunities ii is a cosponsored fund of athyrium capital management lp and nb alternatives specializing in structured capital investments with a focus on loans notes convertible securities preferred stock and other equity royalties royaltybacked debt or other structured instruments in mature stage firms the fund seeks to invest across all healthcare verticals including biopharma medical devices diagnostics healthcare services and healthcare information technology financings by the fund can be made in both public and private companies it prefers to invest globally with a focus on north america europe asia and australia it considers investments between  million and  million detailed description  fifth avenueth floornew york ny united statesfounded in  phone  key executives for athyrium opportunities fund ii lp athyrium opportunities fund ii lp does not have any key executives recorded similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact athyrium opportunities fund ii lp please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close sec info  athyrium opportunities fund iii lp  �d� on  sec info uses javascript� to view pages properly enable javascript in your browser ����sec info������home������search������my interests������help������sign in������please sign in athyrium opportunities fund iii lp � �d��on�on� wednesday  at am et � � � effective�  � � � accession �  � � � file �  ��in� this entire filing an entity search ��show� docs searched �and� every hit the st hit help�wildcards�  any letter�  many� logic� for docs� �and� �or� for text� �anywhere� �near� � ↓bottom � t as of filer filing for�on�as docssize  athyrium opportunities fd iii lp d  kfnotice of an offering of securities made without registration � � � form dfiling table of contents documentexhibit description pages size  d notice of an offering of securities made without html k registration  primarydocxml dp this document is an xml file that may be rendered in various formatsform d �–� plain text �–� edgar system �–� sec website �–� xml listing �–� xml file�� the securities and exchange commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and completethe reader should not assume that the information is accurate and complete ﻿ united states securities and exchange commissionwashington dc form dnotice of exempt offering of securities omb approval omb number  estimated average burden hours per response   issuers identity cik filer id number previous names x none entity type  ﻿ �� corporation x limited partnership �� limited liability company �� general partnership �� business trust �� other specify name of issuer athyrium opportunities fund iii lp jurisdiction of incorporationorganization delaware year of incorporationorganization �� over five years ago x within last five years specify year  �� yet to be formed  principal place of business and contact information name of issuer athyrium opportunities fund iii lp street address  street address  co athyrium capital management lp  fifth avenue floor  city stateprovincecountry zippostalcode phone number of issuer new york new york    related persons last name first name middle name hyman andrew c street address  street address  co athyrium capital management lp  fifth avenue floor  city stateprovincecountry zippostalcode new york new york  relationship x executive officer �� director �� promoter clarification of response if necessary last name first name middle name wakefield paul a street address  street address  co athyrium capital management lp  fifth avenue floor  city stateprovincecountry zippostalcode new york new york  relationship x executive officer �� director �� promoter clarification of response if necessary last name first name middle name paul courtney street address  street address  co athyrium capital management lp  fifth avenue floor  city stateprovincecountry zippostalcode new york new york  relationship x executive officer �� director �� promoter clarification of response if necessary last name first name middle name strong elin street address  street address  co athyrium capital management lp  fifth avenue floor  city stateprovincecountry zippostalcode new york new york  relationship x executive officer �� director �� promoter clarification of response if necessary last name first name middle name ferrell jeffrey a street address  street address  co athyrium capital management lp  fifth avenue floor  city stateprovincecountry zippostalcode new york california  relationship x executive officer �� director �� promoter clarification of response if necessary last name first name middle name lack jeremy d street address  street address  co athyrium capital management lp  fifth avenue floor  city stateprovincecountry zippostalcode new york new york  relationship x executive officer �� director �� promoter clarification of response if necessary  industry group �� agriculture ﻿ banking  financial services ﻿ �� commercial banking �� insurance �� investing �� investment banking x pooled investment fund ﻿ �� hedge fund �� private equity fund �� venture capital fund x other investment fund ﻿ is the issuer registered as an investment company under the investment company act of  ﻿ �� yes x no �� other banking  financial services �� business services ﻿ energy ﻿ �� coal mining ﻿ �� electric utilities ﻿ �� energy conservation ﻿ �� environmental services ﻿ �� oil  gas ﻿ �� other energy ﻿ health care ﻿ �� biotechnology ﻿ �� health insurance ﻿ �� hospitals  physicians ﻿ �� pharmaceuticals ﻿ �� other health care �� manufacturing ﻿ real estate ﻿ �� commercial ﻿ �� construction ﻿ �� reits  finance ﻿ �� residential ﻿ �� other real estate �� retailing �� restaurants ﻿ technology ﻿ �� computers ﻿ �� telecommunications ﻿ �� other technology ﻿ travel ﻿ �� airlines  airports ﻿ �� lodging  conventions ﻿ �� tourism  travel services ﻿ �� other travel �� other  issuer size revenue range or aggregate net asset value range �� no revenues �� no aggregate net asset value ��    ��    ��    ��    ��    ��    ��    ��    �� over  �� over  �� decline to disclose x decline to disclose �� not applicable �� not applicable  federal exemptions and exclusions claimed select all that apply ﻿�� rule b not i ii or iii ﻿�� rule  bi ﻿�� rule  bii ﻿�� rule  biii ﻿�� rule  ﻿x rule b ﻿�� rule c ﻿�� securities act section a x investment company act section c �� section c �� section c�� �� section c �� section c �� section c �� section c �� section c �� section c �� section c �� section c �� section c �� section c x section c  type of filing x new notice ﻿ date of first sale  ﻿ �� first sale yet to occur �� amendment  duration of offering does the issuer intend this offering to last more than one year ﻿ �� yes x no  types of securities offered select all that apply �� equity x pooled investment fund interests �� debt �� tenantincommon securities �� option warrant or other right to acquire another security �� mineral property securities �� security to be acquired upon exercise of option warrant or other right to acquire security �� other describe ﻿ ﻿  business combination transaction is this offering being made in connection with a business combination transaction such as a merger acquisition or exchange offer ﻿ �� yes x no clarification of response if necessary minimum investment minimum investment accepted from any outside investor  usd  sales compensation recipient recipient crd number x none associated broker or dealer x none associated broker or dealer crd number x none street address  street address  city stateprovincecountry zippostal code states of solicitation select all that applycheck �all states� or check individual states �� all states �� foreignnonus  offering and sales amounts total offering amount ﻿ usd or x indefinite total amount sold  usd total remaining to be sold ﻿ usd or x indefinite clarification of response if necessary investors �� select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors and enter the number of such nonaccredited investors who already have invested in the offering ﻿ regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors enter the total number of investors who already have invested in the offering   sales commissions  finders fees expenses provide separately the amounts of sales commissions and finders fees expenses if any if the amount of an expenditure is not known provide an estimate and check the box next to the amount sales commissions  usd �� estimate finders fees  usd �� estimate clarification of response if necessary use of proceeds provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers directors or promoters in response to item  above if the amount is unknown provide an estimate and check the box next to the amount ﻿  usd �� estimate clarification of response if necessarysignature and submission please verify the information you have entered and review the terms of submission below before signing and clicking submit below to file this notice terms of submission in submitting this notice each issuer named above is notifying the sec andor each state in which this notice is filed of the offering of securities described and undertaking to furnish them upon written request in the accordance with applicable law the information furnished to offerees irrevocably appointing each of the secretary of the sec and the securities administrator or other legally designated officer of the state in which the issuer maintains its principal place of business and any state in which this notice is filed as its agents for service of process and agreeing that these persons may accept service on its behalf of any notice process or pleading and further agreeing that such service may be made by registered or certified mail in any federal or state action administrative proceeding or arbitration brought against it in any place subject to the jurisdiction of the united states if the action proceeding or arbitration a arises out of any activity in connection with the offering of securities that is the subject of this notice and b is founded directly or indirectly upon the provisions of� i the securities act of  the securities exchange act of  the trust indenture act of  the investment company act of  or the investment advisers act of  or any rule or regulation under any of these statutes or ii the laws of the state in which the issuer maintains its principal place of business or any state in which this notice is filed certifying that if the issuer is claiming a regulation d exemption for the offering the issuer is not disqualified from relying on regulation d for one of the reasons stated in rule biii or rule d each issuer identified above has read this notice knows the contents to be true and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person for signature type in the signers name or other letters or characters adopted or authorized as the signers signature issuer signature name of signer title date athyrium opportunities fund iii lp andrew c hyman andrew c hyman senior vice president of the gp of the gp   this undertaking does not affect any limits section a of the national securities markets improvement act of  nsmia pub l no   stat  oct   imposes on the ability of states to require information as a result if the securities that are the subject of this form d are covered securities for purposes of nsmia whether in all instances or due to the nature of the offering that is the subject of this form d states cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent nsmia permits them to do so under nsmias preservation of their antifraud authority ↑topfiling submission  � – � alternative formats word  rich text html plain text et�al copyright �  fran finnegan  company� all rights reservedabout – privacy – redactions – help — wed  jul  gmt� athyrium opportunities fund ii nonus lp  who is raising money  sec filings of fundraisings and investments in hedge funds startups and private equity companies who is raising money athyrium opportunities fund ii nonus lp funding details athyrium opportunities fund ii nonus lp industry pooled investment fundcik number address  fifth avenue floor  new york phone number  latest news athyrium opportunities fund ii nonus lp raised  from  investors on  athyrium opportunities fund ii nonus lp filings datefiling typeofferedsoldremainingmin investmentinvest countexemption  exlusions amended form db c csec filingnew form dindefiniteindefiniteb c csec filing athyrium opportunities fund ii nonus lp raised  in total directors and executives of athyrium opportunities fund ii nonus lp key people in athyrium opportunities fund ii nonus lp jeffrey ferrellandrew hymanpaul wakefieldcourtney heizenraderjeremy lack similar companiesathyrium partners lp athyrium opportunities fund b lp athyrium opportunities fund ii lp athyrium opportunities fund iib master lp athyrium opportunities fund iii nonus a lp athyrium opportunities fund iii nonus b lp athyrium opportunities fund iii lp athyrium healthcare strategic income  growth idf llc last visited companies raike real estate income fund llc raike real estate income fund llc restructure opportunity fund llc river green autolife fund ltd river green blended asset fund lp  whoisraisingmoneycom daily updated news about investment into startups hedge funds and private equity companies athyrium capital management lp  financial services firm new york new york  brightscope advisor pages getsearchtypedisplaynamesearchtype advisor funds firms k plans back to top homefirmpagesathyrium capital management lp athyrium capital management lp overviewarticlesholdingsassetsservicesadvisorsleadershipfees share athyrium capital management lp overviewarticlesholdingsassetsservicesadvisorsleadershipfees overview description athyrium capital management lp is a ria based in new york ny with b in aum information type ria head quarters new york ny  of employees  total assets  website location  th ave new york ny   articles insights there are no insights from this firm to display at this time procter  gamble plans competitive but exposure to company stock a risk to participants brightscope editorial firm links there are no links for this firm to display at this time holdings etf holdings there is no etf holding data from this firm to display at this time assets assets last updated on may   b total assets under management na total assets under advisement  accounts m estimated average account balance services firm services there is no services data available to display at this time firm client types advisors current advisors  of advisors  there are no advisors from this firm to display at this time affiliated investment advisors and broker dealers name type total assets athyrium opportunities associates ii lp   athyrium opportunities associates iii lp   athyrium opportunities associates lp   leadership ownership there is no ownership data available to display at this time executives and control persons name title tenure date  ownership jeffrey allen ferrell president january   to  jeremy david lack president january   to  andrew cooper hyman senior vice president and secretary january  less than  paul anthony wakefield senior vice president january  less than  courtney anne paul vice president and assistant secretary january  less than  source sec fees types of compensation arrangements percentage of assets performancebased fees company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations brightscope  advisor pages  find a financial advisor or advisory firm getsearchtypedisplaynamesearchtype advisor funds firms k plans general search advisors advisory firms financial qa k plans funds search home    brightscope advisor pages    find a financial advisory firm advisor search firm search advisors by city find a financial advisory firm search firm name active firms only city state alabama alaska american samoa arizona arkansas california colorado connecticut delaware district of columbia florida georgia guam hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota northern marinara islands ohio oklahoma oregon pennsylvania puerto rico rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming firm service areas financial planning estate planning comprehensive financial planning retirement planning college planning charitable planning other financial planning tax planning insurance life insurance health insurance longterm care insurance annuities property  casualty insurance business insurance other insurance pension consulting k b  defined benefit other pension consulting portfolio management individuals andor small businesses investment companies businesses or institutional clients other portfolio management accounting  tax tax advice other tax legal legal planning legal advice other legal other publication of periodicals or newsletters security ratings or pricing services market timing services selection of other advisors educational seminarsworkshops see all service areas find filters financialplanningfindfirm compensation arrangements no preference fixed fees  hourly charges  performancebased fees  none  fee only  assets under mgmt no preference   k  m  m  m  m  m  m  b  b  avg account balance no preference   k  k  k  k  m  m  m  m  m  financial advisory firm search results  results merrill lynch pierce fenner  smith incorporated ny ny  advisors  aum  b wells fargo advisors llc st louis mo  advisors  aum  b jp morgan securities llc manhattan ny  advisors  aum  b morgan stanley smith barney llc harrison ny  advisors  aum  b lpl financial llc boston ma  advisors  aum  b edward d jones  co lp des peres mo  advisors  aum  b ameriprise financial services inc minneapolis mn  advisors  aum  b ubs financial services inc weehawken nj  advisors  aum  b northwestern mutual investment servicesllc milwaukee wi  advisors charles schwab  co inc south beach ca  advisors mml investors services llc pine point ma  advisors  aum  b goldman sachs  co ny ny  advisors  aum  b strategic advisers inc boston ma  advisors  aum  b citigroup global markets inc new york ny  advisors  aum  b raymond james  associates inc st petersburg fl  advisors  aum  b      company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations athyrium capital management lp  financial services firm new york new york  brightscope advisor pages getsearchtypedisplaynamesearchtype advisor funds firms k plans back to top homefirmpagesathyrium capital management lp athyrium capital management lp overviewarticlesholdingsassetsservicesadvisorsleadershipfees share athyrium capital management lp overviewarticlesholdingsassetsservicesadvisorsleadershipfees overview description athyrium capital management lp is a ria based in new york ny with b in aum information type ria head quarters new york ny  of employees  total assets  website location  th ave new york ny   articles insights there are no insights from this firm to display at this time procter  gamble plans competitive but exposure to company stock a risk to participants brightscope editorial firm links there are no links for this firm to display at this time holdings etf holdings there is no etf holding data from this firm to display at this time assets assets last updated on may   b total assets under management na total assets under advisement  accounts m estimated average account balance services firm services there is no services data available to display at this time firm client types advisors current advisors  of advisors  there are no advisors from this firm to display at this time affiliated investment advisors and broker dealers name type total assets athyrium opportunities associates ii lp   athyrium opportunities associates iii lp   athyrium opportunities associates lp   leadership ownership there is no ownership data available to display at this time executives and control persons name title tenure date  ownership jeffrey allen ferrell president january   to  jeremy david lack president january   to  andrew cooper hyman senior vice president and secretary january  less than  paul anthony wakefield senior vice president january  less than  courtney anne paul vice president and assistant secretary january  less than  source sec fees types of compensation arrangements percentage of assets performancebased fees company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations athyrium opportunities fund iii nonus b lp  list of ceos founders and company directors directorpedianet  list of ceos founders board members and company directors athyrium opportunities fund iii nonus b lp list of persons related to the company athyrium opportunities fund iii nonus b lp find out list of ceos founders board members and company directors of athyrium opportunities fund iii nonus b lp cik number company address co athyrium capital management lp  fifth avenue floor  new york phone number  people related to athyrium opportunities fund iii nonus b lp namepositionstreetcitycountryc hyman andrewco athyrium capital management lp  fifth avenue floor new yorknypaul courtneyco athyrium capital management lp  fifth avenue floor new yorknystrong elinco athyrium capital management lp  fifth avenue floor new yorknya ferrell jeffreyco athyrium capital management lp  fifth avenue floor new yorknyd lack jeremyco athyrium capital management lp  fifth avenue floor new yorknya wakefield paulco athyrium capital management lp  fifth avenue floor new yorkny athyrium opportunities fund iii nonus b lp on the web related companiesathyrium healthcare strategic income  growth idf llc athyrium opportunities fund b lp athyrium opportunities fund ii nonus lp athyrium opportunities fund ii lp athyrium opportunities fund iib master lp athyrium opportunities fund iii nonus a lp athyrium opportunities fund iii lp athyrium partners lp athyrium opportunities fund closes at  mln  pe hub subscribe to pe hub wire join over  of your peers get the mustread email for pevc professionals delivered to your inbox daily — for free us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions subscribe yes no registersign in a community for professionals in private capital athyrium opportunities fund closes at  mln may   by luisa beltran follow luisarbeltran print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub athyrium opportunities fund closes at  mln athyrium opportunities fund lp a private credit fund which invests in healthcare sector has closed at  million the fund which was oversubscribed is jointly managed by neuberger berman and athyrium capital management athyrium opportunities seeks to make – million financings in small to mediumsized healthcare companies in the us europe and asia continue reading on pe hub writes athyrium opportunities fund lp a private credit fund which invests in healthcare sector has closed at  million the fund which was oversubscribed is jointly managed by neuberger berman and athyrium capital management athyrium opportunities seeks to make – million financings in small to mediumsized healthcare companies in the us europe and asia press release new york may   – neuberger berman group llc one of the world’s leading employeecontrolled money managers and athyrium capital management an asset management company focused on opportunities in the global healthcare sector announced the closing of athyrium opportunities fund lp the “fund” or “athyrium opportunities” a private credit fund that seeks to invest in a diversified pool of incomegenerating structured investments in the global healthcare sector athyrium opportunities was oversubscribed closing at  million athyrium opportunities seeks to make – million financings in small to mediumsized healthcare companies in the us europe and asia the fund focuses on partnering with management teams of pharmaceutical medical device and diagnostics companies with commercialstage products and services who are looking for long term capital to grow their businesses the fund seeks to generate current income and capital gains for its investors and has significant flexibility in structuring its investments – possible transaction structures include loans notes royalties or royaltybacked debt preferred stock convertible or other structured securities the fund has made five investments to date representing over  of committed capital the fund is jointly managed by neuberger berman and athyrium capital management neuberger berman’s alternatives business “nb alternatives” and athyrium capital management formed a strategic relationship in  to source close and manage structured investments in the healthcare sector since forming the strategic relationship the team has completed more than a dozen transactions including both the fund’s and its predecessor’s investments the fund’s senior investment team is comprised of cohead jeffrey ferrell founder and managing partner of athyrium capital management cohead samuel porat managing director at nb alternatives and laurent hermouet and richard pines partners at athyrium capital management “client response to the athyrium opportunities fund has been high and we’re thankful for the trust our investors have placed in us” said samuel porat cohead of the fund “our aim is to create a diversified portfolio of investments that can generate relatively high current income while also offering a level of downside protection commensurate with fixed income investments” the fund’s global investor base is comprised of more than  institutional investors including public and private pensions insurance companies fundsoffunds endowments and foundations “small and mediumsized companies often have limited access to the capital markets and other sources of financing and the athyrium opportunities fund offers these companies an attractive alternative for their capital needs while limiting potential equity dilution” said jeffrey ferrell cohead of the fund “our goal is to customize capital solutions that meet our investment objectives while providing flexible and creative capital solutions to the industry our investment team has its roots in the private equity business and this informs how we approach our relationship with portfolio company management” about athyrium capital management athyrium capital management llc is an secregistered asset management company formed in  to focus on investment opportunities in the global healthcare sector athyrium invests across all healthcare verticals including biopharma medical devices and products and healthcare services and partners with management teams to implement creative financing solutions to companies’ capital needs the athyrium team has substantial investment experience in the healthcare sector across a wide range of asset classes including public equity private equity fixed income royalties and other structured securities athyrium has over  million under management as of march   the firm’s investors include public and corporate pension funds charitable endowments insurance companies fundsoffunds family offices and university endowments for more information please visit wwwathyriumcom about neuberger berman neuberger berman is a private independent employeecontrolled investment manager it partners with institutions advisors and individuals throughout the world to customize solutions that address their needs for income growth and capital preservation with more than  professionals focused exclusively on asset management it offers an investment culture of independent thinking founded in  the company provides solutions across equities fixed income hedge funds and private equity and had  billion in assets under management as of march   for more information please visit our website at wwwnbcom print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub athyrium opportunities fund closes at  mln athyrium opportunities fund lp a private credit fund which invests in healthcare sector has closed at  million the fund which was oversubscribed is jointly managed by neuberger berman and athyrium capital management athyrium opportunities seeks to make – million financings in small to mediumsized healthcare companies in the us europe and asia continue reading on pe hub writes dont miss out meet new and diverse managers in private equity venture capital and real estate at the third emerging manager connect east at new york citys harvard club click here for details sign up to our newsletter receive updates from our pe hub wire and top stories of the week newsletters first name last name email address us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions you are now subscribed to the pehub wire and top stories of the week newsletters buyouts insiderargosy group llc produces several free newsletters that are sent directly to the email you provide at registration namely pe hub wire pe hub canada wire pe hub wire top story of the week buyouts daily and vcj alert to enable us to keep providing these services free of charge we reserve the right to contact you with special invitations to sample or purchase private equityrelated products by submitting this free subscription request for any of these products you are also consenting to this communication should you ever wish to unsubscribe from a particular communication you may activate the unsubscribe mechanism at the bottom of the email this will discontinue both the special invitations mentioned previously as well as your subscription to the weekly newsletter the information you provide will be safeguarded by argosy group llcbuyouts insider the company’s subsidiaries may use it to keep you informed of relevant products and services we occasionally allow reputable companies outside of the company to mail details of products which may be of interest to you as an international group we may transfer your data on a global basis for the purposes indicated above we will never share your email or contact details with any outside company however should you have any questions please do not hesitate to contact us email protected top posts new oil and gas company native racks up  mln by iris dorbian bain capital double impact funds two companies by iris dorbian midocean to sell water pik for  bln by luisa beltran kkr to buy nature’s bounty from carlyle by luisa beltran carlyle to invest in zerochaos by luisa beltran blackrock leads funding round for fintech platform icapital by iris dorbian awake security nabs over  mln from greylock and bain capital ventures by iris dorbian the pe hub podcast episode two by staff report